Sexual function and dysfunction in older HIV-positive individuals

References

[1]  Russell DB. The sexual response. In: Russell D, Bradford D, Fairley C, editors. Sexual health medicine, 2nd edition. Melbourne: IP Communications; 2011. pp. 42–50.

[2]  Golub SA, Tamassilli JC, Pantalone DW, Brennan M, Karpiak SE, Parsons JT. Prevalence and correlates of sexual behaviour and risk management among HIV-positive adults over 50. Sex Transm Dis 2010; 37 615–20.

[3]  Grierson J, Power J, Pitts M, Croy S, Clement T, Thorpe R, et al. HIV futures 6: making positive lives count. Monograph series number 74. Melbourne: The Australian Research Centre in Sex, Health and Society, LaTrobe University; 2009.

[4]  Florence E, Schrooten W, Dreezen C, Gordillo V, Nilsson Schönnesson L, Asboe D, et al Prevalence and factors associated with sexual dysfunction among HIV-positive women in Europe. AIDS Care 2004; 16 550–7.
| Prevalence and factors associated with sexual dysfunction among HIV-positive women in Europe.Crossref | GoogleScholarGoogle Scholar |

[5]  Schrooten W, Colebunders R, Youle M, Molenberghs G, Dedes N, Koitz G, et al Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral therapy. AIDS 2001; 15 1019–23.

[6]  Goldmeier D, Kocsis A, Wasserman M. Sexual dysfunction in women with HIV. Sex Transm Infect 2005; 81 284
| Sexual dysfunction in women with HIV.Crossref | GoogleScholarGoogle Scholar |

[7]  Wilson TE, Jean-Louis G, Schwartz R, Golub ET, Cohen MH, Maki P, et al HIV infection and women’s sexual functioning. J Acquir Immune Defic Syndr 2010; 54 360–7.

[8]  De Tubinho Scanavino M, Najjar Abdo CH. Sexual dysfunctions among people living with AIDS in Brazil. Clinics 2010; 65 511–9.
| Sexual dysfunctions among people living with AIDS in Brazil.Crossref | GoogleScholarGoogle Scholar |

[9]  Schoenbaum EE, Hartel D, Lo Y, Floris-Moore M, Arnsten JH, Santoro N. HIV infection drug use, and onset of natural menopause. Clin Infect Dis 2005; 41 1517–24.
| HIV infection drug use, and onset of natural menopause.Crossref | GoogleScholarGoogle Scholar |

[10]  Van der Voort DJ, van der Weijer PH, Barentsen R. Early menopause increased fracture risk at older age. Osteoporos Int 2003; 14 525–30.
| Early menopause increased fracture risk at older age.Crossref | GoogleScholarGoogle Scholar |

[11]  Van der Klift M, de Laet CE, McCloskey EV, Johnell O, Kanis JA, Hofman A, et al Risk factors for incident vertebral fractures in men and women: the Rotterdam study. J Bone Miner Res 2004; 19 1172–80.
| Risk factors for incident vertebral fractures in men and women: the Rotterdam study.Crossref | GoogleScholarGoogle Scholar |

[12]  Hu FB, Grodstein F, Hennekens CH, Colditz GA, Johnson M, Manson JE, et al Age at natural menopause and risk of cardiovascular disease. Arch Intern Med 1999; 159 1061–6.
| Age at natural menopause and risk of cardiovascular disease.Crossref | GoogleScholarGoogle Scholar |

[13]  Ossewaarde ME, Bots ML, Verbeek AL, Peeters PH, van der Graaf Y, Grobbee DE, et al Age at menopause, cause-specific mortality and total life expectance. Epidemiology 2005; 16 556–62.
| Age at menopause, cause-specific mortality and total life expectance.Crossref | GoogleScholarGoogle Scholar |

[14]  Atsma F, Bartelink ML, Grobbee DE, van der Schouw YT. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause 2006; 13 265–79.
| Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis.Crossref | GoogleScholarGoogle Scholar |

[15]  Bell C, Richardson D, Wall M, Goldmeier D. HIV-associated female sexual dysfunction – clinical experience and literature review. Int J STD AIDS 2006; 17 706–9.
| HIV-associated female sexual dysfunction – clinical experience and literature review.Crossref | GoogleScholarGoogle Scholar |

[16]  Beutel ME, Weidner W, Brahler E. Epidemiology of sexual dysfunction in the male population. Andrologia 2006; 38 115–21.
| Epidemiology of sexual dysfunction in the male population.Crossref | GoogleScholarGoogle Scholar |

[17]  Cohan P, Korenman SG. Erectile dysfunction. J Clin Endocrinol Metab 2001; 86 2391–4.
| Erectile dysfunction.Crossref | GoogleScholarGoogle Scholar |

[18]  Moreno-Pérez O, Escoin C, Serna-Candel C, Picó A, Alfayate R, Merino E, et al Risk factors for sexual and erectile dysfunction in HIV-infected men: the role of protease inhibitors. AIDS 2010; 24 255–64.
| Risk factors for sexual and erectile dysfunction in HIV-infected men: the role of protease inhibitors.Crossref | GoogleScholarGoogle Scholar |

[19]  Crum-Cianflone NF, Bavaro M, Hale B, Amling C, Truett A, Brandt C, et al Erectile dysfunction and hypogonadism among men with HIV. AIDS Patient Care STDS 2007; 21 9–19.
| Erectile dysfunction and hypogonadism among men with HIV.Crossref | GoogleScholarGoogle Scholar |

[20]  Ende AR, Lo Re V, DiNubile MJ, Mounzer K. Erectile dysfunction in an urban HIV-positive population. AIDS Patient Care STDS 2006; 20 75–8.
| Erectile dysfunction in an urban HIV-positive population.Crossref | GoogleScholarGoogle Scholar |

[21]  Guaraldi G, Luzi K, Murri R, Granata A, De Paola M, Orland G, et al Sexual dysfunction in HIV-infected men: role of antiretroviral therapy, hypogonadism and lipodystrophy. Antivir Ther 2007; 12 1059–65.

[22]  Collazos J. Sexual dysfunction in the highly active antiretroviral therapy era. AIDS Rev 2007; 9 237–45.

[23]  Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. DHHS; 2011. Available online at: http://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf[verified March 2011].

[24]  Trotta MP, Ammassari A, Murri R, Marconi P, Zaccarelli M, Cozzi-Lepri A, et al Self-reported sexual dysfunction is frequent among HIV-infected persons and is associated with suboptimal adherence to antiretrovirals. AIDS Patient Care STDs 2008; 22 291–9.
| Self-reported sexual dysfunction is frequent among HIV-infected persons and is associated with suboptimal adherence to antiretrovirals.Crossref | GoogleScholarGoogle Scholar |

[25]  Sollima S, Osio M, Muscia F, Gambaro P, Alciati A, Zucconi M, et al Protease inhibitors and erectile dysfunction. AIDS 2001; 15 2331–3.
| Protease inhibitors and erectile dysfunction.Crossref | GoogleScholarGoogle Scholar |

[26]  Colson A, Keller M, Sax P, Pettus P, Platt R, Choo P. Male sexual dysfunction associated with antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 30 27–32.

[27]  Bernal E, Masia M, Padilla S, Gutierrez F. Unexpected improvement of sexual dysfunction during atazanavir therapy. AIDS 2005; 19 1440–1.
| Unexpected improvement of sexual dysfunction during atazanavir therapy.Crossref | GoogleScholarGoogle Scholar |

[28]  Crum-Cianflone N, Bavaro M, Hale B, Amling C, Truett A, Brandt C, et al Erectile dysfunction and hypogonadism among men with HIV. AIDS Patient Care STDs 2007; 21 9–19.
| Erectile dysfunction and hypogonadism among men with HIV.Crossref | GoogleScholarGoogle Scholar |

[29]  Murri R, Fantoni M, Del Borgo C, Longo B, Deiana G, Visonà R, et al Nonnucleoside reverse transcriptase inhibitor-containing regimens are associated with increased satisfaction with sexual life. J Acquir Immune Defic Syndr 2003; 34 532–4.
| Nonnucleoside reverse transcriptase inhibitor-containing regimens are associated with increased satisfaction with sexual life.Crossref | GoogleScholarGoogle Scholar |

[30]  Collazos J, Mayo J, Martinez E, Ibarra S. Association between sexual disturbances and sexual hormones with specific antiretroviral drugs. AIDS 2002; 16 1294–5.
| Association between sexual disturbances and sexual hormones with specific antiretroviral drugs.Crossref | GoogleScholarGoogle Scholar |

[31]  van Leeuwen MT, Vajdic CM, Middleton MG, McDonald AM, Law M, Kaldor JM, et al Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy. AIDS 2009; 23 2183–90.
| Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy.Crossref | GoogleScholarGoogle Scholar |

[32]  Park IU, Palefsky JM. Evaluation and management of anal intraepithelial neoplasia in HIV-negative and HIV-positive men who have sex with men. Curr Infect Dis Rep 2010; 12 126–33.
| Evaluation and management of anal intraepithelial neoplasia in HIV-negative and HIV-positive men who have sex with men.Crossref | GoogleScholarGoogle Scholar |

[33]  Ho KS, Cranston RD. Anal cytology screening in HIV-positive men who have sex with men: what’s new and what’s now? Curr Opin Infect Dis 2010; 23 21–5.
| Anal cytology screening in HIV-positive men who have sex with men: what’s new and what’s now?Crossref | GoogleScholarGoogle Scholar |

[34]  Cardoso SW, Grinsztejn B, Velasque L, Veloso VG, Luz PM, Friedman RK, et al Incidence of modifying or discontinuing first HAART regimen and its determinants in a cohort of HIV-infected patients from Rio de Janeiro, Brazil. AIDS Res Hum Retroviruses 2010; 26 865–74.
| Incidence of modifying or discontinuing first HAART regimen and its determinants in a cohort of HIV-infected patients from Rio de Janeiro, Brazil.Crossref | GoogleScholarGoogle Scholar |

[35]  Moyle G, Moutschen M, Martínez E, Domingo P, Guaraldi G, Raffi F, et al Epidemiology, assessment, and management of excess abdominal fat in persons with HIV infection. AIDS Rev 2010; 12 3–14.

[36]  Rosen RC, Cappelleri JC, Gendrano N. The International Index of Erectile Dysfunction (IIEF): a state-of-the-science-review. Int J Impot Res 2002; 14 226–44.
| The International Index of Erectile Dysfunction (IIEF): a state-of-the-science-review.Crossref | GoogleScholarGoogle Scholar |

[37]  Coyne K, Mandelia S, McCullough S, Catlan J, Noestlinger C, Colebunders R, et al The International Index of Erectile Dysfunction: development of an adapted tool for use in HIV-positive men who have sex with men. J Sex Med 2010; 7 769–74.
| The International Index of Erectile Dysfunction: development of an adapted tool for use in HIV-positive men who have sex with men.Crossref | GoogleScholarGoogle Scholar |

[38]  Dolan Looby SE, Collins M, Lee H, Grinspoon S. Effects of long-term testosterone administration in HIV-infected women: a randomized, placebo-controlled trial. AIDS 2009; 23 951–9.
| Effects of long-term testosterone administration in HIV-infected women: a randomized, placebo-controlled trial.Crossref | GoogleScholarGoogle Scholar |

[39]  Davison SL, Davis SR. Androgenic hormones and aging – the link with female sexual function. Horm Behav 2011;
| Androgenic hormones and aging – the link with female sexual function.Crossref | GoogleScholarGoogle Scholar |

[40]  Smith KJ, Roberts MS. The cost-effectiveness of sildenafil. Ann Intern Med 2000; 132 933–7.

[41]  Cook RL, McGinnis KA, Samet JH, Fiellin DA, Rodriquez-Barradas MD, Kraemer KL, et al Erectile dysfunction drug receipt, risky sexual behavior and sexually transmitted disease in HIV-infected and HIV-uninfected men. J Gen Intern Med 2010; 25 115–21.
| Erectile dysfunction drug receipt, risky sexual behavior and sexually transmitted disease in HIV-infected and HIV-uninfected men.Crossref | GoogleScholarGoogle Scholar |

[42]  Cooperman NA, Arnsten JH, Klein RS. Current sexual activity and risky sexual behavior in older men with or at risk for HIV infection. AIDS Educ Prev 2007; 19 321–33.
| Current sexual activity and risky sexual behavior in older men with or at risk for HIV infection.Crossref | GoogleScholarGoogle Scholar |